期刊文献+

32例舒张性心衰的诊治分析 被引量:4

Treatment and Analysis for 32 Cases of Diastolic Heart Failure
原文传递
导出
摘要 目的探讨舒张性心功能不全的临床特点和治疗方法。方法对32例以舒张性心功能不全为主要临床表现的患者的治疗进行回顾性分析。结果所有患者经积极有效治疗均于1周后纠正心衰,心功能得到改善。结论改善心肌血供氧供,降低心肌氧耗,减轻和逆转心肌肥厚和重塑,增加左室顺应性,可有效预防和纠正舒张功能不全性心衰。 Objective Investigate the clinical characteristics and treatment method of diastolic dysfunction. Methods To Process retrospective analyses by reviewing therapy for 32 patients, whose clinical manifestations are mainly diastolic dysfunction. Results All patients' heart failure had been cured and their heart function had also been improved after one weeks' active and effective treatment. Conclusion Improving blood supply and oxygen delivery for cardiac muscle, decreasing its oxygen consumption, reducing and reversing cardiac hypertrophy with remodeling, plus increasing cardiac compliance for left ventricle, all of above methods can actively prevent and correct heart failure caused by diastolic dysfunction.
作者 陈劲
出处 《中华全科医学》 2009年第7期698-699,共2页 Chinese Journal of General Practice
关键词 舒张性心衰 诊断 治疗 Diastolic Heart Failure Diagnosi Therapy
  • 相关文献

参考文献5

二级参考文献56

  • 1[1]Vasan Rs,Levy D:Defining diastolic heart failure:a call for standardized diastolic criteria. Circulation,2000,101:2118 - 2121
  • 2[2]Zile MR, Gaasch WH, Carroll JD, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation,2001,104: 779 - 782
  • 3[3]Chari Y T et al: Diastolic Heart Failure in the Community. Current Cardiology Reports,2000,2:461 - 469
  • 4[4]Alpert NR, LeWinter M, Mulieri LA, et al. Chemomechanical energy transduction in the failing heart. Heart Faliure Rev, 1999,4:281 -295
  • 5[5]Kazuhiro Yamamoto et al. Roles of renin - angiotensin and endothelin systems in the development of diastolic heart failure in hyprtensive hearts. Cardiovascular Research,2000,47:274 - 283
  • 6[6]Kazuhiro Yamamoto et al. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hyperfensive heart disease: absence of AT reeptor downregulation and ‘overdrive' of the endothelin system. Cardiovascular Research,2000,46: 421 - 432
  • 7[7]Christina J, Marit M, Margareta R, et al. Doppler tissue imaging in congestive heart failure patients due to diastolic orsystolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique. Euro J of Heart Failure, 2000,2:151 - 160
  • 8[9]Zile MR; Brustsaet DL. New Concepts in Diastolic Dysfunction and Diastolic Heart Failure. Circulation,2002:105,106:1387 - 1393,1503 - 1508
  • 9[1]Maron BJ, Casey SA, Poliac LC et al. Clinical course of hypertrophic cardiomyopathy in a regional united cohort[J]. JAMA, 1999,281(7):650-655.
  • 10[2]Maron MS, Olivotto I, Betocchi S. Effect of left ventricular outflow tract obstruction on the clinical outcom in hypertrophic cardiomyopathy[J]. N Engl J Med, 2003,348(4): 295-303.

共引文献55

同被引文献22

  • 1陈颖,陆红.舒张性心力衰竭的诊断与治疗进展[J].中国全科医学,2008,11(20):1882-1884. 被引量:12
  • 2齐玉琴,魏国,葛才荣.肥厚性心肌病的临床研究现状[J].医学研究生学报,2004,17(8):753-755. 被引量:7
  • 3闫丽辉,何昆仑,范利.高血压与舒张性心力衰竭[J].中国老年学杂志,2007,27(1):87-90. 被引量:7
  • 4Peter Libby, Eugene Braunwald, ScienceDirect (Online service), et al. Braunwald's heart disease:a textbook of cardiovascular medicine, 第8版 .Philadelphia :Saunders/Elsevier, 2008.435-606.
  • 5黄宇,顾水明,魏盟.他汀类药物对舒张性心衰的分子生物学机制[J].国际心血管病杂志,2007,34(1):60-62. 被引量:17
  • 6ANASTASAKIS A, THEOPISTOU A, RIGOPOULOS A, et al. Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic eardiomyopathy cohort [ J ]. Hellenic J Cardiol, 2013,54 (4) :281-288.
  • 7SMITH K M,SQUIERS J. Hypertrophic eardiomyopathy: an overview[ J ]. Crit Care Nuts Clin North Am,2013,25 (2) : 263 -272.
  • 8DESNOS M. Hypertrophic cardiomyopathy: current aspects and new developments [ J]. Bull Acad Natl Meal,2012,196 (4-5) :997-1009.
  • 9MARON B J, MARON M S. Hypertrophic cardiomyopathy [ J]. Lancet ,2013,381 (9862) :242-255.
  • 10MUHIB S, FUJINO T, SATO N, et al. Epicardial adipose tissue is associated with prevalent atrial fibrillation in patients with hypertrophic cardiomyopathy [ J ]. Int Heart J, 2013,54(5) :297-303.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部